Skip to main content
FRMSL logo

FRMSL — Investor Relations & Filings

Ticker · 4746 ISIN · TW0004746003 TW Manufacturing
Filings indexed 1,872 across all filing types
Latest filing 2022-03-10 Regulatory Filings
Country TW Taiwan
Listing TW 4746

About FRMSL

www.formosalab.com

Formosa Laboratories, Inc. is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company provides integrated services ranging from process development and custom synthesis to large-scale commercial manufacturing. Its core product portfolio includes UV-filters, Vitamin D derivatives, and polymers such as cholesterol and phosphate binders. Formosa Laboratories offers specialized expertise in Antibody-Drug Conjugates (ADCs) and injectable manufacturing, including cytotoxic and freeze-dried products. Maintaining high quality standards, its facilities are cGMP-compliant and have been successfully inspected by the US FDA, TFDA, EDQM, and PMDA. The company serves a global clientele, providing one-stop solutions for complex chemical synthesis, fermentation, and peptide production.

Recent filings

Filing Released Lang Actions
董事會通過110年度合併財務報告
Regulatory Filings Classification · 95% confidence The document is a brief announcement from a company (ticker 4746 台耀) reporting that the board of directors has approved the consolidated financial report for the fiscal year 110 (which corresponds to 2021). It includes summarized financial data such as revenue, gross profit, operating loss, net profit before tax, net profit, net profit attributable to parent company owners, earnings per share, total assets, total liabilities, and equity. The document length is only 902 characters, which is quite short and resembles a regulatory announcement rather than a full annual report. There is no detailed financial statement or comprehensive analysis present, only summarized figures and a statement of board approval. According to the "Menu vs Meal" rule, such a short document announcing the approval of a financial report is best classified as a Regulatory Filing (RNS) rather than the full Annual Report (10-K).
2022-03-10 Chinese
110年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 100% confidence The document contains detailed information about dividend distribution, including cash dividends per share, dates of board resolutions and shareholder meetings, and explanations of dividend policies. It focuses on the announcement of dividend amounts and related shareholder distribution details. There is no indication of a full annual or interim financial report, audit report, or other types of filings. The content matches the description of a Notice of Dividend Amount, which announces dividend amounts, payment dates, and details for shareholders.
2022-03-10 Chinese
本公司受邀參加凱基證券舉辦之線上法人說明會
Investor Presentation Classification · 90% confidence The document is a brief announcement about the company participating in an online investor presentation hosted by a securities firm. It includes details such as the date, time, location (online), and the main topic (company's future strategy and vision). There are no financial statements or detailed financial data included. The document is short (674 characters) and serves as a notice of an upcoming investor presentation rather than the presentation itself or a detailed report. Therefore, it fits the category of Investor Presentation (IP).
2022-03-09 Chinese
111年02月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, with no financial statements, earnings data, or management discussion. There is no indication of an annual report, earnings release, or other financial report. The document is not a brief announcement but a detailed disclosure of insider holdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2022-03-07 Chinese
111年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, supervisors, and executives. It lists their current holdings, pledged shares, and related ratios. The content is focused on insider shareholdings and pledges, which corresponds to reporting of personal share transactions or holdings by company directors and executives. There is no indication of financial results, management discussion, or other report types. The document is not a report publication announcement or a certification. Therefore, the document fits the category of Director's Dealing (DIRS). The document length is about 4619 characters, which is sufficient for a detailed insider shareholding report rather than a brief announcement.
2022-03-07 Chinese
111年2月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (台耀) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, nor does it mention any report publication or certification. The content is a regulatory disclosure of financial guarantees and loans, typical of a Regulatory Filing (RNS) category, as it does not fit into more specific report types like Annual Report, Interim Report, or Capital Update. The document length is short and purely informational without being a report or announcement of a report.
2022-03-04 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.